Metabolic score: Insights on the development and prediction of remission of Metabolic syndrome after gastric bypass

Annals of Surgery

Volumn 260, Issue 2, 2014, Pages 279-286

  Faria, Gil ^a   Pestana, Diogo ^a   Aral, Marisa ^b   Preto, John ^b   Norberto, Sónia ^a   Calhau, Conceição ^a   Guimarães, Jõao T ^a,b,c   Taveira Gomes, Antonio ^a,b  

^a University of Porto   (Portugal)

^b São João Medical Center   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Gastric bypass; Metabolic syndrome; Obesity; Predictive score; Type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; ABDOMINAL FAT; AGE; ANALYSIS; ANATOMY AND HISTOLOGY; BLOOD; COMPLICATION; OBESITY, MORBID; PORTUGAL; PREDICTIVE VALUE; RISK FACTOR; TREATMENT OUTCOME;

ABDOMINAL FAT; ADULT; AGE FACTORS; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; FEMALE; GASTRIC BYPASS; HUMANS; HYPERTENSION; LIPOPROTEINS, HDL; MALE; METABOLIC SYNDROME X; OBESITY, MORBID; PORTUGAL; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84905595415     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000686     Document Type: Article

References (62)

1. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645.
2. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480.
3. Williams S, Cunningham E, Pories WJ. Surgical treatment of metabolic syndrome. Med Princ Pract. 2012;21:301-309.
4. Lee W-J, Huang M-T, Wang W, et al. Effects of obesity surgery on the metabolic syndrome. Arch Surg. 2004;139:1088-1092.
5. Ikramuddin S, Buchwald H. How bariatric and metabolic operations control metabolic syndrome. Br J Surg. 2011;98:1339-1341.
6. Bray GA, Ryan DH, Harsha DW. Diet, weight loss, and cardiovascular disease prevention. Curr Treat Options Cardiovasc Med. 2003;5:259-269.
7. Inabnet WB, Winegar DA, Sherif B, et al. Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database. J Am Coll Surg. 2012;214:550-556.
8. Batsis JA, Romero-Corral A, Collazo-Clavell ML, et al. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc. 2008;83:897-907.
9. Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.
10. Adams TD, Gress RE, Smith SC, et al. Long-termmortality after gastric bypass surgery. N Engl J Med. 2007;357:753-761.
11. Christou N, Maclean L. Effect of bariatric surgery on long-term mortality. Adv Surg. 2005;39:165-179.
12. Tejirian T, Jensen C, Dutson E. Bariatric surgery and type 2 diabetes mellitus: surgically induced remission. J Diab Sci Tech. 2008;2:685-691.
13. Gass M, Beglinger C, Peterli R. Metabolic surgery-principles and current concepts. Langenbecks Arch Surg. 2011;396:949-72.
14. Friedewald W, Levy R. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
15. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
16. Athyros VG, Tziomalos K, Karagiannis A, et al. Cardiovascular benefits of bariatric surgery in morbidly obese patients. Obes Rev. 2011;12:515-524.
17. Saboya C, Arasaki CH, Matos D, et al. Relationship between the preoperative body mass index and the resolution of metabolic syndrome following Rouxen-Y gastric bypass. Metab Syndr Relat Disord. 2012;10:292-296.
18. Kim LJ, Nalls MA, Eiriksdottir G, et al. Associations of visceral and liver fat with the metabolic syndrome across the spectrum of obesity: the AGESReykjavik study. Obesity. 2011;19:1265-1271.
19. Gracia-Solanas JA, Elia M, Aguilella V, et al. Metabolic syndrome after bariatric surgery. Results depending on the technique performed. Obes Surg. 2011;21:179-185.
20. Madan AK, Orth W, Ternovits CA, et al. Metabolic syndrome: yet another comorbidity gastric bypass helps cure. Surg Obes Relat Dis. 2006;2:48-51.
21. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2:367-373.
22. Stroh C, Groh C, Weiner R, et al. Are there gender-specific aspects of gastric banding? Data analysis from the quality assurance study of the surgical treatment of obesity in Germany. Obes Surg. 2013;23:1783-1789.
23. Taylor SA, Hergenroeder AC. Waist circumference predicts increased cardiometabolic risk in normal weight adolescent males. Int J Pediatr Obes. 2011;6:307-311.
24. The NS, Richardson AS, Gordon-Larsen P. Timing and duration of obesity in relation to diabetes: findings from an ethnically diverse, nationally representative sample. Diabetes Care. 2013;36:865-872.
25. Harwood HJ. The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology. 2012;63:57-75.
26. Hammarstedt A, Graham TE, Kahn BB. Adipose tissue dysregulation and reduced insulin sensitivity in nonobese individuals with enlarged abdominal adipose cells. Diabetol Metab Syndr. 2012;4:42.
27. Kabir M, Stefanovski D, Hsu IR, et al. Large size cells in the visceral adipose depot predict insulin resistance in the canine model. Obesity. 2011;19:2121-2129.
28. O'Connell J, Lynch L, Cawood TJ, et al. The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS One. 2010;5:e9997.
29. Klöting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocr Metab. 2010;299:E506-E515.
30. Srdić B, Stokić E, Korać A, et al. Morphological characteristics of abdominal adipose tissue in normal-weight and obese women of different metabolic profiles. Exper Clin Endocr Diab. 2010;8:713-718.
31. Monteiro R, de Castro PMST, Calhau C, et al. Adipocyte size and liability to cell death. Obes Surg. 2006;16:804-806.
32. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46:2347-2355.
33. Bays HE, Laferrère B, Dixon J, et al. Adiposopathy and bariatric surgery: is "sick fat" a surgical disease? Int J Clin Pract. 2009;63:1285-1300.
34. Hardy OT, Perugini RA, Nicoloro SM, et al. Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity. Surg Obes Relat Dis. 2011;7:60-67.
35. Veilleux A, Caron-Jobin M, Noël S, et al. Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes. 2011;60:1504-1511.
36. Hoffstedt J, Arner E, Wahrenberg H, et al. Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia. 2010;53:2496-2503.
37. Mattar SG, Velcu LM, Rabinovitz M, et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg. 2005;242:610-617.
38. Gazzaruso C, Giordanetti S, La Manna A, et al. Weight loss after Swedish Adjustable Gastric Banding: relationships to insulin resistance and metabolic syndrome. Obes Surg. 2002;12:841-845.
39. Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007;17:176-184.
40. Ali MR, Fuller WD, Rasmussen J. Detailed description of early response of metabolic syndrome after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5:346-351.
41. Carvalho PS, Moreira CL, Barelli Mda C, et al. [Can bariatric surgery cure metabolic syndrome?]. Arq Bras Endocrinol Metab. 2007;51:79-85.
42. Hofsø D, Nordstrand N, Johnson LK, et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol. 2010;163:735-745.
43. Rossi M, Serpa Neto A, Rossi FMB, et al. Percentage of excess BMI lost correlates better with improvement of metabolic syndrome after Roux-en-Y gastric bypass in morbidly obese subjects: anthropometric indexes and gastric bypass. Surg Obes Relat Dis. 2009;5:11-18.
44. Scozzari G, Passera R, Benvenga R, et al. Age as a long-term prognostic factor in bariatric surgery. Ann Surg. 2012;256:724-729.
45. Ortega E, Morínigo R, Flores L, et al. Predictive factors of excess body weight loss 1 year after laparoscopic bariatric surgery. Surg Endosc. 2012;26:1744-1750.
46. Perna M, Romagnuolo J, Morgan K, et al. Preoperative hemoglobin A1c and postoperative glucose control in outcomes after gastric bypass for obesity. Surg Obes Relat Dis. 2012;8:685-690.
47. Faria G, Preto J, Almeida AB, et al. Fasting glycemia: a good predictor of weight loss after RYGB. Surg Obes Relat Dis. 2013; S1550-7289:00324-00329.
48. Faria G, Preto J, da Costa EL, et al. Acute improvement in insulin resistance after laparoscopicRoux-en-Y gastric bypass: is 3 days enough to correct insulin metabolism? Obes Surg. 2013;23:103-110.
49. Wickremesekera K, Miller G, Naotunne TD, et al. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg. 2005;15:474-481.
50. Rao RS, Yanagisawa R, Kini S. Insulin resistance and bariatric surgery. Obes Rev. 2012;13:316-328.
51. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752.
52. Rizzello M, De Angelis F, Campanile FC, et al. Effect of gastrointestinal surgical manipulation on metabolic syndrome: a focus on metabolic surgery. Gastroenterol Res Pract. 2012;2012:10.
53. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-1737.
54. Kini S, Herron DM, Yanagisawa RT. Bariatric surgery for morbid obesity-a cure for metabolic syndrome? Med Clin N Am. 2007;91:1255-1271.
55. Hinojosa MW, Varela JE, Smith BR, et al. Resolution of systemic hypertension after laparoscopic gastric bypass. J Gastrointest Surg. 2009;13:793-797.
56. Rossi M, Barretto Fereira da Silva R, Chaves Alcântara G, et al. Remission of metabolic syndrome: a study of 140 patients six months after Roux-en-Y gastric bypass. Obes Surg. 2008;18:601-606.
57. Iannelli A, Anty R, Piche T, et al. Impact of laparoscopic Roux-en-Y gastric bypass on metabolic syndrome, inflammation, and insulin resistance in super versus morbidly obese women. Obes Surg. 2009;19:577-582.
58. Nugent C, Bai C, Elariny H, et al. Metabolic syndrome after laparoscopic bariatric surgery. Obes Surg. 2008;18:1278-1286.
59. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248-256.
60. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a nonobese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1-11.
61. Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35:1420-1428.
62. Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment.. Diabetes Care. 2013;36:2175-2182.